Products for Research Use Only
RegisterLogin

(R) -Zevaquenabant

CAT: 0931-TYD-02102-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-TYD-02102-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Cannabinoid Receptor, NO Synthase
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Bioactivity
(R) -Zevaquenabant ((R) -MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S) -MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS) . It is beneficial in improving chronic kidney disease (CKD) caused by obesity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T39410Zevaquenabant
T39074-01(Rac)-Zevaquenabant
T202978-01(R, R) -Voriconazole
T19540-01(R, R) - (+) -Hydrobenzoin
T23227(R, R) -THC
T12640-01(R, R) -Glycopyrrolate
T31688-01Ethambutol, (R, R) -
TYD-02662-01(R, R) -LRRK2-IN-7
TJS20511-01(R,R)-Secoisolariciresinol diglucoside
T207587-01(R, R) -BMS-986397

Alternative Products

CatalogName
MBS5799898Zevaquenabant
GTR19253432-01(R) -Zevaquenabant
HY-141411-01(Rac) -Zevaquenabant
MBS5785473-01(Rac)-Zevaquenabant

Popular Products